Table 2. Association with MFN2 expression and clinical pathologic variables (logistic regression).
| Clinical characteristics | Total | Odds ratio in MFN2 expression (95% CI) | P value |
|---|---|---|---|
| Stage (IV vs. I) | 126 | 0.29 (0.13–0.59) | 0.001 |
| Distant metastasis (M1 vs. M0) | 379 | 0.31 (0.16–0.55) | <0.001 |
| Age (≥60 vs.<60 years) | 379 | 1.07 (0.70–1.63) | 0.749 |
| Gender (male vs. female) | 379 | 0.78 (0.53–1.13) | 0.184 |
| T stage (T4 vs. T1) | 51 | 0.20 (0.04–0.81) | 0.033 |
| Lymph nodes (N2 vs. N0) | 291 | 0.62 (0.37–1.02) | 0.063 |
MFN2, mitofusin 2; CI, confidence interval.